Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Nootropics / Racetams and ampakines

49 In the index

Fasoracetam FASO

A brain-supplement compound studied in human trials for ADHD and, earlier, for cognitive problems after a stroke. A children's ADHD trial didn't show it worked, and it remains unapproved anywhere for any use.

Also known as NS-105, Fasoracetam [INN], N-(5-Oxo-D-prolyl)piperidine, NS 105 (pharmaceutical), NFC1 ANHYDROUS, NFC-1 ANHYDROUS, 42O8UF5CJB, NS 105

Effects Focus Mood
Routes Oral
Legal status Research chemical
WADA Not listed

3D Molecular Structure of C10H16N2O2

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Nitrogen
  • Oxygen

Chemistry

Formula
C10H16N2O2
Molar mass
196.25
CAS
110958-19-5
PubChem CID
198695
IUPAC name
(5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
InChIKey
GOWRRBABHQUJMX-MRVPVSSYSA-N

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 10 mg per dose
Reported range 10-100 mg/day
Route Oral
Frequency 1-3 times daily
Duration Ongoing (supplement use)

Studied in small trials for ADHD and cognitive impairment but never completed FDA approval; sold as an unregulated nootropic supplement.

Where this comes from Early clinical trials; supplement-industry dosing

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.